Anti-CFAP206 monoclonal antibody

Pre-made anti-CFAP206 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CFAP206/CFAP206 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2423-Ab-1/ GM-Tg-hg-IP2423-Ab-2Anti-Human CFAP206 monoclonal antibodyHuman
GM-Tg-rg-IP2423-Ab-1/ GM-Tg-rg-IP2423-Ab-2Anti-Rat CFAP206 monoclonal antibodyRat
GM-Tg-mg-IP2423-Ab-1/ GM-Tg-mg-IP2423-Ab-2Anti-Mouse CFAP206 monoclonal antibodyMouse
GM-Tg-cynog-IP2423-Ab-1/ GM-Tg-cynog-IP2423-Ab-2Anti-Cynomolgus/ Rhesus macaque CFAP206 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2423-Ab-1/ GM-Tg-felg-IP2423-Ab-2Anti-Feline CFAP206 monoclonal antibodyFeline
GM-Tg-cang-IP2423-Ab-1/ GM-Tg-cang-IP2423-Ab-2Anti-Canine CFAP206 monoclonal antibodyCanine
GM-Tg-bovg-IP2423-Ab-1/ GM-Tg-bovg-IP2423-Ab-2Anti-Bovine CFAP206 monoclonal antibodyBovine
GM-Tg-equg-IP2423-Ab-1/ GM-Tg-equg-IP2423-Ab-2Anti-Equine CFAP206 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2423-Ab-1/ GM-Tg-hg-IP2423-Ab-2; GM-Tg-rg-IP2423-Ab-1/ GM-Tg-rg-IP2423-Ab-2;
GM-Tg-mg-IP2423-Ab-1/ GM-Tg-mg-IP2423-Ab-2; GM-Tg-cynog-IP2423-Ab-1/ GM-Tg-cynog-IP2423-Ab-2;
GM-Tg-felg-IP2423-Ab-1/ GM-Tg-felg-IP2423-Ab-2; GM-Tg-cang-IP2423-Ab-1/ GM-Tg-cang-IP2423-Ab-2;
GM-Tg-bovg-IP2423-Ab-1/ GM-Tg-bovg-IP2423-Ab-2; GM-Tg-equg-IP2423-Ab-1/ GM-Tg-equg-IP2423-Ab-2
Products NameAnti-CFAP206 monoclonal antibody
Formatmab
Target NameCFAP206
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CFAP206 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2423-Ag-1Recombinant multi-species CF206/ CFAP206/ C6orf165 protein


    Target information

    Target IDGM-IP2423
    Target NameCFAP206
    Gene ID154313,69329,366347,700665,474990,101089267,513096,100065642
    Gene Symbol and Synonyms1700003M02Rik,C10H6orf165,C12H6orf165,C4H6orf165,C6orf165,C9H6orf165,CFAP206,dJ382I10.1,RGD1310641
    Uniprot AccessionQ8IYR0,A1A5Q4,Q29RL1
    Uniprot Entry NameCF206_HUMAN,CF206_RAT,CF206_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000272514
    Target ClassificationN/A

    The target: CFAP206, gene name: CFAP206, also named as C6orf165, dJ382I10.1. Predicted to be involved in regulation of cilium beat frequency; regulation of flagellated sperm motility; and sperm axoneme assembly. Predicted to be located in motile cilium. Predicted to be part of radial spoke. Predicted to be active in axoneme and ciliary basal body. Predicted to colocalize with A axonemal microtubule. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.